Literature DB >> 9479635

Expression of the cyclooxygenase-2 gene in gastric epithelium.

H Sawaoka1, S Tsuji, M Tsujii, E S Gunawan, A Nakama, Y Takei, K Nagano, H Matsui, S Kawano, M Hori.   

Abstract

This study examined the mRNA level of cyclooxygenase-2 (cox-2) in a rat gastric mucosal cell line after growth stimulation in vitro and in rat gastric mucosa before and after acid-induced injury in vivo. RGMI cells were stimulated with fetal calf serum in the in vitro study. Thereafter, the cox-2 mRNA level was examined by Northern analysis. Effects of NS-398, a specific inhibitor of cox-2, and indomethacin on prostaglandin production and cell proliferation were examined in RGM1 cells. In the in vivo study, rats were given 1 ml of 0.6 N hydrochloric acid into the stomach. The level of cox-2 mRNA was examined in rat gastric mucosa after acid administration. Cox-2 mRNA increased 20-60 min after growth stimulation in RGM1 cells. Both NS-398 and indomethacin suppressed prostaglandin production and cell proliferation after growth stimulation. Expression of cox-2 mRNA was observed 40 and 60 min after administration of 0.6 N HCl. Gastric lesions developed within 60 min after HCl administration and healed significantly within 48 h. The present study shows the expression of cox-2 in gastric epithelial cells in vitro and in gastric mucosa after injury in vivo. The results also suggest that cox-2 is involved in de novo synthesis of prostaglandins and cell proliferation in gastric epithelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9479635     DOI: 10.1097/00004836-199700001-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Neoplastic transformation and induction of H+,K+ -adenosine triphosphatase by N-methyl-N'-nitro-N-nitrosoguanidine in the gastric epithelial RGM-1 cell line.

Authors:  Osamu Shimokawa; Hirofumi Matsui; Yumiko Nagano; Tsuyoshi Kaneko; Takeshi Shibahara; Akira Nakahara; Ichinosuke Hyodo; Akinori Yanaka; Hideyuki J Majima; Yukio Nakamura; Yasushi Matsuzaki
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-11-22       Impact factor: 2.416

Review 2.  Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.

Authors:  John L Wallace; Pallavi R Devchand
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 3.  Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors:  F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 4.  Cellular and molecular aspects of gastric cancer.

Authors:  Malcolm-G Smith; Georgina-L Hold; Eiichi Tahara; Emad-M El-Omar
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 5.  Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Authors:  Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

Authors:  Samir Malhotra; N Shafiq; P Pandhi
Journal:  MedGenMed       Date:  2004-03-23

7.  Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk.

Authors:  V Sibilia; F Pagani; G Rindi; N Lattuada; D Rapetti; V De Luca; N Campanini; I Bulgarelli; V Locatelli; F Guidobono; C Netti
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

8.  COX and NOS isoforms involved in acid-induced duodenal bicarbonate secretion in rats.

Authors:  Koji Takeuchi; Shigeru Kagawa; Hiroshi Mimaki; Masako Aoi; Shoji Kawauchi
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.

Authors:  Bettina Berenguer; Catalina Alarcón De La Lastra; Virginia Motilva; Carmen La Casa; Juan Manuel Herrerias; David Pozo; María José Martin Calero
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

10.  Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.

Authors:  Peter Nagi; Selwyn M Vickers; Julia Davydova; Yasuo Adachi; Koichi Takayama; Shannon Barker; Victor Krasnykh; David T Curiel; Masato Yamamoto
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.